Granahan Investment Management - MELINTA THERAPEUTICS INC ownership

MELINTA THERAPEUTICS INC's ticker is MLNTQ and the CUSIP is 58549G209. A total of 53 filers reported holding MELINTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of MELINTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$128,000
-86.0%
241,853
+0.4%
0.01%
-88.0%
Q3 2019$917,000
-38.0%
240,771
+8.2%
0.05%
-31.5%
Q2 2019$1,480,000
+82.0%
222,571
-2.8%
0.07%
+65.9%
Q1 2019$813,000229,0300.04%
Other shareholders
MELINTA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Granahan Investment Management 222,571$1,480,0000.07%
BOENNING & SCATTERGOOD, INC. 22,500$149,0000.04%
CONDOR CAPITAL MANAGEMENT 14,000$93,0000.01%
STIFEL FINANCIAL CORP 267,666$1,780,0000.01%
Sculptor Capital LP 237,000$1,576,0000.00%
Sculptor Capital LP 247,000$1,642,0000.00%
Palo Alto Investors LP 10,137$67,0000.00%
Paloma Partners Management Co 30,800$205,0000.00%
AlphaMark Advisors, LLC 780$5,0000.00%
Renaissance Technologies 243,932$1,622,0000.00%
View complete list of MELINTA THERAPEUTICS INC shareholders